Bas‐jan van der Leede

Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies

Mike O’Donovan, Marlies De Boeck, Dominique Brault et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2010 · 110 citations

Pharmacy, Pharmacology, Toxicology +11

Optimisation of the cell cultivation methods in the embryonic stem cell test results in an increased differentiation potential of the cells into strong beating myocard cells

Ann De Smedt, Margino Steemans, Marlies De Boeck et al. · Toxicology in Vitro · 2008 · 37 citations

Life Sciences, Cell Biology, Developmental Biology +17

Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk/benefit to patients

Sophie Lachau‐Durand, Lieve Lammens, Bas‐jan van der Leede et al. · PLoS neglected tropical diseases · 2019 · 33 citations · Full text

Pharmacy, Pharmacology, Toxicology +15

Flow cytometric analysis of micronucleated reticulocytes: Time- and dose-dependent response of known mutagens in mice, using multiple blood sampling

Marlies De Boeck, Bas‐jan van der Leede, Freddy Van Goethem et al. · Environmental and Molecular Mutagenesis · 2005 · 28 citations

Pharmacy, Cell Biology, Toxicology +17

Abstract 5690: Discovery of JNJ-67856633: A novel, first-in-class MALT1 protease inhibitor for the treatment of B cell lymphomas

Ulrike Philippar, Tianbao Lu, Nele Vloemans et al. · Cancer Research · 2020 · 15 citations

Life Sciences, Oncology, Pharmacology +14